Florida 2025 1st Special Session

Florida House Bill HB1421

Caption

Improving Screening for and Treatment of Blood Clots:

Summary

HB 1421, titled the "Emily Adkins Family Protection Act," is a health care and patient-safety bill focused on improving the screening, treatment, reporting, and public awareness of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. It revises the state’s chronic disease findings to recognize VTE as a significant health concern and requires hospitals with emergency departments and ambulatory surgical centers to adopt evidence-based policies for identifying at-risk patients, using a nationally recognized risk assessment tool, and training nonphysician staff annually on VTE-related procedures and emergency response. The bill also creates a statewide VTE registry to be contracted out by the Department of Health to a qualified private nonprofit entity at no cost to the state. Beginning July 1, 2026, hospitals with emergency departments must regularly report specified VTE data, including patient demographics, diagnosis method, treatment recommendations, and whether the patient was a nursing home or assisted living resident. The registry is limited to medical research and education uses, and the Department of Health must submit a detailed report to state leaders by June 1, 2026 using inpatient and outpatient data from the prior year. In addition to hospital reporting and registry requirements, the bill expands training expectations for nursing home certified nursing assistants. It adds VTE recognition and emergency response to annual inservice education and to the additional training required for CNAs who are delegated medication-administration tasks. The bill also prohibits using additional Medicaid funding through interim rate adjustments to reimburse the cost of this added training. The bill further amends assisted living facility consumer information requirements. It directs facilities to provide residents upon admission with a pamphlet explaining VTE, including risk factors and signs and symptoms, and it reinforces the state’s consumer-information framework for assisted living facilities. The bill takes effect July 1, 2025 and is intended to improve awareness, early detection, and outcomes for blood clot-related conditions across acute care, long-term care, and assisted living settings. Overall sentiment appears strongly supportive and public-health oriented, with the bill framed as a patient-protection measure and enacted into law without recorded committee transcript opposition or vote detail in the provided materials. The main points of potential contention are administrative and operational: hospitals and facilities must add training, reporting, and policy requirements, while the state must rely on a private nonprofit registry operator and manage new data collection and reporting obligations. Privacy and data-use limits are addressed by restricting registry information to research and education purposes.

Impact

The bill amends sections of Florida law governing chronic disease findings, hospital patient safety, nursing assistant training, and assisted living consumer information. It creates a new statutory section establishing a statewide venous thromboembolism registry, imposes new reporting duties on hospitals with emergency departments, requires hospitals and ambulatory surgical centers to adopt VTE screening and treatment policies, expands CNA training requirements in nursing homes, and requires assisted living facilities to provide VTE educational materials to residents. It also directs the Department of Health and the Agency for Health Care Administration to produce reports and administer the new requirements, affecting hospitals, ambulatory surgical centers, nursing homes, assisted living facilities, and a contracted private nonprofit registry operator.

Sentiment

The available context suggests the bill was viewed favorably and passed into law as a patient-safety and public-health measure. The title, findings, and structure emphasize prevention, early diagnosis, education, and improved outcomes for blood clot patients, and there is no recorded committee transcript or vote history in the provided materials indicating organized opposition. The overall tone is protective and reform-oriented rather than controversial.

Contention

No specific floor or committee objections are provided, but the bill’s likely points of contention are practical rather than ideological. Hospitals and long-term care facilities may object to the added compliance burden, including annual staff training, new screening protocols, and regular data reporting. The registry model may also raise questions about data collection, privacy, and the selection of the private nonprofit entity to operate the statewide system, though the bill limits use of registry data to research and education and specifies that the registry must be provided at no cost to the state.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.